Purchase Order 36C25625P0856

Award Date 3/31/25
Potential Completion Date 6/30/25
Potential Value $50K
Contracting Federal Agency
Veterans Integrated Service Network 16
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the procurement of Novocure's Optune device, a cancer treatment technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $49,748.73, was awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), specifically the Veterans Integrated Service Network 12 (VISN 12). The contract is...
This federal contract award is for Novocure Inc., a foreign-owned, for-profit medical device manufacturer, to provide the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with its Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $16,582.91, is a firm fixed-price delivery order awarded under Novocure's $28.85 million Federal Supply Schedule...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune Plus transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers. The contract is structured as a firm fixed-price purchase order with a...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This contract does not utilize any set-aside designations and is being...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, a component of the company's Tumor Treating Fields (TTFields) cancer therapy technology, over a 3-month period. This award is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is a firm-fixed-price purchase order for the delivery of Novocure's Optune Tumor Treating Fields (TTFields) therapy transducers and related support services. The contract does not utilize any set-aside designations and is part of Novocure's 5-year Federal Supply...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 delivery order contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is a delivery order under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices,...

This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. This contract does not utilize a set-aside designation, likely due to the specialized nature of Novocure's medical device offerings. Novocure holds a significant Federal Supply Schedule (FSS) contract with the VA VHA, valued at $28.85 million and running through October 31, 2027, which serves as a primary procurement vehicle for the VA to obtain Novocure's medical technologies. This specific contract award is structured as a firm fixed-price purchase order, enabling VA facilities to acquire Novocure's cutting-edge cancer treatment technologies for use in serving veteran patients.

Generated 5/7/25, 9:49 AM